Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 2
Submit an article Journal homepage
546
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluation

Profiling lasmiditan as a treatment option for migraine

Martina CurtoDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy;International Mood & Psychotic Disorders Research Consortium, Mailman Research Center, Belmont, MA, USA;Department of Mental Health, ASL Roma 5, Colleferro (RM), ItalyView further author information
,
Fabiola CipollaDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, ItalyView further author information
,
Giusy Ylenia CisaleDepartment of Physiology and Pharmacology, Sapienza University of Rome, Rome, ItalyView further author information
,
Matilde CapiMass Spectrometry Laboratory Unit, Sant’Andrea University Hospital, Rome, ItalyView further author information
,
Valerio SpuntarelliDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, ItalyView further author information
,
Martina GuglielmettiDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy;Regional Referral Headache Center, Sant’Andrea University Hospital, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-5567-5297View further author information
ORCID Icon,
Paolo MartellettiDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy;Regional Referral Headache Center, Sant’Andrea University Hospital, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6556-4128View further author information
ORCID Icon &
Luana LionettoMass Spectrometry Laboratory Unit, Sant’Andrea University Hospital, Rome, ItalyView further author information
 show all
Pages 147-153 | Received 03 Sep 2019, Accepted 13 Nov 2019, Published online: 25 Nov 2019

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Karissa Johnston, Evan Popoff, Alison Deighton, Parisa Dabirvaziri, Linda Harris, Alexandra Thiry, Robert Croop, Vladimir Coric, Gilbert L’Italien & James Moren. (2022) Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis. Expert Review of Pharmacoeconomics & Outcomes Research 22:1, pages 155-166.
Read now
Sui-yi Xu, Hui-juan Li, Jing Huang, Xiu-ping Li & Chang-xin Li. (2021) Migraine with Brainstem Aura Accompanied by Disorders of Consciousness. Journal of Pain Research 14, pages 1119-1127.
Read now
Daniele Martinelli, Vito Bitetto & Cristina Tassorelli. (2021) Lasmiditan: an additional therapeutic option for the acute treatment of migraine. Expert Review of Neurotherapeutics 21:5, pages 491-502.
Read now
Wade Cooper, Erin Gautier Doty, Helen Hochstetler, Ann Hake & Vincent Martin. (2020) The current state of acute treatment for migraine in adults in the United States. Postgraduate Medicine 132:7, pages 581-589.
Read now

Articles from other publishers (13)

Dilara Onan, William Wells-Gatnik & Paolo Martelletti. (2022) Reaching the Nadir of Medication Overuse in Chronic Migraine. International Journal of Environmental Research and Public Health 19:22, pages 14696.
Crossref
Giovanna Viticchi, Lorenzo Falsetti, Mauro Silvestrini & Marco Bartolini. (2022) Ditans: a new prospective for the therapy of migraine attack?. Neurological Sciences 43:9, pages 5709-5716.
Crossref
Paolo Martelletti. 2022. Migraine in Medicine. Migraine in Medicine 639 881 .
Simy Parikh. 2022. Novel Synthetic Drugs in Migraine. Novel Synthetic Drugs in Migraine 83 95 .
Eduardo Rivera-Mancilla & Antoinette MaassenVanDenBrink. 2022. Novel Synthetic Drugs in Migraine. Novel Synthetic Drugs in Migraine 1 17 .
Paul A DeJulio, Joshua K Perese, Nathaniel M Schuster & Jessica C Oswald. (2021) Lasmiditan for the acute treatment of migraine. Pain Management 11:5, pages 437-449.
Crossref
Max Tsai, Emel Serap Monkul Nery, Lisa Kerr, Rashna Khanna, Mika Komori, Ellen B. Dennehy, Darren Wilbraham & Paul Winner. (2021) Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine. Clinical Pharmacokinetics 60:6, pages 819-828.
Crossref
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, Ottavia De Luca, Fabiola Cipolla, Luana Lionetto, Maurizio Simmaco & Paolo Martelletti. (2021) CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine. Journal of Clinical Medicine 10:7, pages 1429.
Crossref
Anna Ferrari & Cecilia Rustichelli. (2021) Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative Review. Clinical Therapeutics 43:4, pages 654-670.
Crossref
Arpita Maitra, Sabyasachi Mukhopadhyay, Abhijit Das & Shouvik Choudhury. (2021) Newer Horizon for Treatment of Acute Attack of Migraine: Lasmiditan and Ubrogepant. Neurology India 69:6, pages 1759.
Crossref
Danuta Szkutnik-Fiedler. (2020) Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies. Pharmaceutics 12:12, pages 1180.
Crossref
J. C. A. Edvinsson, A. Viganò, A. Alekseeva, E. Alieva, R. Arruda, C. De Luca, N. D’Ettore, I. Frattale, M. Kurnukhina, N. Macerola, E. Malenkova, M. Maiorova, A. Novikova, P. Řehulka, V. Rapaccini, O. Roshchina, G. Vanderschueren, L. Zvaune, A. P. Andreou & K. A. Haanes. (2020) The fifth cranial nerve in headaches. The Journal of Headache and Pain 21:1.
Crossref
Alok Singh, Dhyuti Gupta & Ajaya Kumar Sahoo. (2020) Acute Migraine: Can the New Drugs Clinically Outpace?. SN Comprehensive Clinical Medicine 2:8, pages 1132-1138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.